Local, exendin-(9-39)-insensitive, site of action of GLP-1 in canine ileum (Q33184111)

23 July 2017

Local, exendin-(9-39)-insensitive, site of action of GLP-1 in canine ileum (English)

1 reference

23 July 2017

E E Daniel

1

1 reference

23 July 2017

M Anvari

series ordinal

2

1 reference

23 July 2017

J E T Fox-Threlkeld

series ordinal

3

1 reference

23 July 2017

T J McDonald

series ordinal

4

1 reference

23 July 2017

1 September 2002

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

23 July 2017

1 reference

23 July 2017

283

1 reference

23 July 2017

3

1 reference

23 July 2017

G595-602

1 reference

Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice.

23 July 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Extrinsic and intrinsic neural control of pyloric sphincter pressure in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Effects of GLP-1 on gastric emptying, antropyloric motility, and transpyloric flow in response to a nonnutrient liquid

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Glucagon-like peptide-1 (7-36) amide as a novel neuropeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Long-lasting antidiabetic effect of a dipeptidyl peptidase IV-resistant analog of glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Role of nitric oxide-related inhibition in intestinal function: relation to vasoactive intestinal polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

The tachykinin receptors inducing contractile responses of canine ileum circular muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Minireview: the glucagon-like peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Substance P: a potent inhibitor of the canine small intestine in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Exogenous opiates: their local mechanisms of action in the canine small intestine and stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Activation of endogenous excitatory opiate pathways in canine small intestine by field stimulation and motilin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Sites and mechanisms of action of neuropeptides on canine gastric motility differ and

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

The mechanism of motilin excitation of the canine small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Stimulation of circular muscle motility of the isolated perfused canine ileum: Relationship to VIP output

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Peptidergic regulation of gastrointestinal motility in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Glucagonlike peptide-1 (GLP-1) participation in ileal brake induced by intraluminal peptones in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Release of VIP and substance P from isolated perfused canine ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Gastric emptying and release of incretin hormones after glucose ingestion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Tissue-specific and glucose-dependent expression of receptor genes for glucagon and glucagon-like peptide-1 (GLP-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression1This work was supported by a grant from the Crohn's and Colitis Foundation of America.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00110.2002

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00110.2002

1 reference

23 July 2017

1 reference